 Richard Blaszak
Concepts (141)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency | 3 | 2023 | 113 | 1.090 |
Why?
| | Acute Kidney Injury | 4 | 2023 | 319 | 0.770 |
Why?
| | Peritoneal Dialysis | 4 | 2019 | 33 | 0.700 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 187 | 0.660 |
Why?
| | Kidney Transplantation | 3 | 2020 | 192 | 0.570 |
Why?
| | Peritonitis | 3 | 2019 | 27 | 0.430 |
Why?
| | Hypothermia, Induced | 2 | 2023 | 40 | 0.380 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2023 | 60 | 0.370 |
Why?
| | Respiration, Artificial | 1 | 2012 | 308 | 0.320 |
Why?
| | Wounds and Injuries | 1 | 2012 | 309 | 0.310 |
Why?
| | Hyperuricemia | 1 | 2007 | 7 | 0.270 |
Why?
| | Graft Survival | 1 | 2008 | 160 | 0.270 |
Why?
| | Uric Acid | 1 | 2007 | 25 | 0.270 |
Why?
| | Graft Rejection | 1 | 2008 | 177 | 0.270 |
Why?
| | Peritoneal Dialysis, Continuous Ambulatory | 1 | 2006 | 6 | 0.260 |
Why?
| | Ceftazidime | 1 | 2006 | 8 | 0.260 |
Why?
| | Child | 10 | 2023 | 7248 | 0.240 |
Why?
| | Child, Preschool | 9 | 2021 | 4076 | 0.240 |
Why?
| | Phosphates | 1 | 2005 | 49 | 0.240 |
Why?
| | Cardiopulmonary Bypass | 1 | 2005 | 95 | 0.230 |
Why?
| | Infant | 8 | 2023 | 3733 | 0.210 |
Why?
| | Appendix | 1 | 2003 | 23 | 0.210 |
Why?
| | Ureter | 1 | 2003 | 36 | 0.210 |
Why?
| | Renal Replacement Therapy | 1 | 2023 | 34 | 0.200 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2022 | 16 | 0.200 |
Why?
| | Patient Education as Topic | 1 | 2005 | 321 | 0.190 |
Why?
| | Humans | 22 | 2023 | 52483 | 0.180 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2021 | 15 | 0.180 |
Why?
| | Heart Transplantation | 3 | 2011 | 367 | 0.170 |
Why?
| | Caregivers | 1 | 2023 | 240 | 0.170 |
Why?
| | Kidney Failure, Chronic | 3 | 2019 | 210 | 0.170 |
Why?
| | Prospective Studies | 5 | 2022 | 2481 | 0.170 |
Why?
| | Male | 14 | 2021 | 26761 | 0.170 |
Why?
| | Anti-Bacterial Agents | 1 | 2006 | 807 | 0.160 |
Why?
| | Cryopreservation | 1 | 2020 | 41 | 0.160 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2020 | 117 | 0.160 |
Why?
| | Adolescent | 7 | 2012 | 6739 | 0.150 |
Why?
| | Catheters, Indwelling | 1 | 2019 | 58 | 0.150 |
Why?
| | Catheter-Related Infections | 1 | 2019 | 49 | 0.150 |
Why?
| | Infant, Newborn | 4 | 2023 | 2867 | 0.150 |
Why?
| | Kidney | 3 | 2023 | 707 | 0.150 |
Why?
| | Heart Diseases | 1 | 2021 | 216 | 0.150 |
Why?
| | Risk Factors | 6 | 2019 | 3889 | 0.150 |
Why?
| | Female | 13 | 2023 | 28171 | 0.140 |
Why?
| | Cystatin C | 2 | 2021 | 10 | 0.140 |
Why?
| | Quality of Life | 1 | 2023 | 879 | 0.140 |
Why?
| | Heart Failure | 1 | 2022 | 565 | 0.130 |
Why?
| | Mitochondria | 1 | 2020 | 430 | 0.130 |
Why?
| | Hospital Mortality | 2 | 2021 | 435 | 0.120 |
Why?
| | Treatment Outcome | 4 | 2020 | 5422 | 0.110 |
Why?
| | Time Factors | 4 | 2019 | 2968 | 0.100 |
Why?
| | Lipocalins | 1 | 2011 | 13 | 0.090 |
Why?
| | Acute-Phase Proteins | 1 | 2011 | 24 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 151 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2021 | 6607 | 0.080 |
Why?
| | Disease Progression | 1 | 2012 | 871 | 0.080 |
Why?
| | Risk Assessment | 2 | 2019 | 1327 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2012 | 2279 | 0.080 |
Why?
| | Congresses as Topic | 1 | 2009 | 48 | 0.080 |
Why?
| | Suture Techniques | 1 | 2008 | 60 | 0.070 |
Why?
| | Catheterization | 1 | 2008 | 96 | 0.070 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 150 | 0.070 |
Why?
| | Urate Oxidase | 1 | 2007 | 5 | 0.070 |
Why?
| | Acid-Base Equilibrium | 1 | 2007 | 9 | 0.070 |
Why?
| | Bone Density | 1 | 2009 | 399 | 0.070 |
Why?
| | Prognosis | 1 | 2012 | 2099 | 0.070 |
Why?
| | Education, Medical, Graduate | 1 | 2009 | 219 | 0.070 |
Why?
| | Professional-Family Relations | 1 | 2007 | 44 | 0.070 |
Why?
| | Hospitals, Teaching | 1 | 2007 | 54 | 0.070 |
Why?
| | Laparoscopy | 1 | 2008 | 180 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2008 | 443 | 0.070 |
Why?
| | Fluid Therapy | 1 | 2007 | 78 | 0.070 |
Why?
| | Arkansas | 1 | 2012 | 2028 | 0.060 |
Why?
| | Hemodialysis Solutions | 1 | 2006 | 3 | 0.060 |
Why?
| | Clinical Competence | 1 | 2009 | 406 | 0.060 |
Why?
| | Pediatrics | 1 | 2009 | 293 | 0.060 |
Why?
| | Program Development | 1 | 2007 | 165 | 0.060 |
Why?
| | Young Adult | 2 | 2012 | 4329 | 0.060 |
Why?
| | Phosphorus | 1 | 2005 | 29 | 0.060 |
Why?
| | Patient-Centered Care | 1 | 2007 | 141 | 0.060 |
Why?
| | Creatinine | 1 | 2005 | 150 | 0.060 |
Why?
| | Biopsy | 1 | 2007 | 605 | 0.060 |
Why?
| | Registries | 1 | 2008 | 581 | 0.060 |
Why?
| | Introns | 1 | 2004 | 53 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2005 | 149 | 0.050 |
Why?
| | Pilot Projects | 1 | 2006 | 721 | 0.050 |
Why?
| | Calcium | 1 | 2005 | 376 | 0.050 |
Why?
| | Cadaver | 1 | 2003 | 96 | 0.050 |
Why?
| | Dialysis | 1 | 2022 | 7 | 0.050 |
Why?
| | DNA Replication | 1 | 2004 | 160 | 0.050 |
Why?
| | Necrosis | 1 | 2003 | 176 | 0.050 |
Why?
| | Urethra | 1 | 2003 | 98 | 0.050 |
Why?
| | Proteinuria | 1 | 2002 | 39 | 0.050 |
Why?
| | Hematuria | 1 | 2002 | 26 | 0.050 |
Why?
| | Oximetry | 1 | 2023 | 66 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2005 | 488 | 0.050 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2021 | 12 | 0.050 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 28 | 0.050 |
Why?
| | Interleukin-18 | 1 | 2021 | 27 | 0.050 |
Why?
| | Renal Dialysis | 1 | 2022 | 179 | 0.040 |
Why?
| | North America | 1 | 2021 | 73 | 0.040 |
Why?
| | Proteins | 1 | 2004 | 348 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2005 | 509 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 82 | 0.040 |
Why?
| | Ultrasonography | 1 | 2022 | 430 | 0.040 |
Why?
| | DNA | 1 | 2004 | 549 | 0.040 |
Why?
| | Heart Arrest | 1 | 2021 | 158 | 0.040 |
Why?
| | Lung | 1 | 2022 | 509 | 0.040 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2021 | 295 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2020 | 421 | 0.040 |
Why?
| | Adult | 2 | 2022 | 14161 | 0.040 |
Why?
| | Cohort Studies | 1 | 2021 | 1542 | 0.030 |
Why?
| | Age Factors | 1 | 2019 | 1132 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 2680 | 0.030 |
Why?
| | Blood Urea Nitrogen | 1 | 2011 | 42 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 124 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 558 | 0.020 |
Why?
| | Accreditation | 1 | 2009 | 62 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 162 | 0.020 |
Why?
| | Mortality | 1 | 2009 | 105 | 0.020 |
Why?
| | Problem-Based Learning | 1 | 2009 | 51 | 0.020 |
Why?
| | Laparotomy | 1 | 2008 | 37 | 0.020 |
Why?
| | Foreign-Body Migration | 1 | 2008 | 31 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 145 | 0.020 |
Why?
| | Pelvis | 1 | 2008 | 69 | 0.020 |
Why?
| | Fractures, Bone | 1 | 2009 | 107 | 0.020 |
Why?
| | Educational Measurement | 1 | 2009 | 196 | 0.020 |
Why?
| | Program Evaluation | 1 | 2009 | 353 | 0.020 |
Why?
| | Decision Making | 1 | 2009 | 282 | 0.020 |
Why?
| | Reoperation | 1 | 2008 | 465 | 0.020 |
Why?
| | Curriculum | 1 | 2009 | 398 | 0.020 |
Why?
| | Patient Care Team | 1 | 2007 | 272 | 0.010 |
Why?
| | Students, Medical | 1 | 2007 | 159 | 0.010 |
Why?
| | Simian virus 40 | 1 | 2004 | 14 | 0.010 |
Why?
| | TRPP Cation Channels | 1 | 2004 | 4 | 0.010 |
Why?
| | Thermodynamics | 1 | 2004 | 35 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2004 | 90 | 0.010 |
Why?
| | Internship and Residency | 1 | 2009 | 448 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 208 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 1006 | 0.010 |
Why?
| | HeLa Cells | 1 | 2004 | 265 | 0.010 |
Why?
|
|
Blaszak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|